Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study Article Swipe

PDF

Tessa G. Steenbruggen , Astrid N. Scholten , M-J.T. Vrancken-Peeters , Ingrid A.M. Mandjes , M. Holtkamp , Jelle Wesseling , SC Linn , Gabe S. Sonke ·

YOU? · · 2017 · Open Access · · DOI: https://doi.org/10.1093/annonc/mdx365.077

Related Topics

Concepts

Medicine Chemotherapy Carboplatin Breast cancer Metastatic breast cancer Oncology Internal medicine ThioTEPA Cancer Induction chemotherapy Surgery Cyclophosphamide Cisplatin

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/annonc/mdx365.077
PDF: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf
OA Status: bronze
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W2763740706

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W2763740706

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/annonc/mdx365.077

Digital Object Identifier
Title: Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2017

Year of publication
Publication date: 2017-09-01

Full publication date if available
Authors: Tessa G. Steenbruggen, Astrid N. Scholten, M-J.T. Vrancken-Peeters, Ingrid A.M. Mandjes, M. Holtkamp, Jelle Wesseling, SC Linn, Gabe S. Sonke

List of authors in order
Landing page: https://doi.org/10.1093/annonc/mdx365.077

Publisher landing page
PDF URL: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf

Direct OA link when available
Concepts: Medicine, Chemotherapy, Carboplatin, Breast cancer, Metastatic breast cancer, Oncology, Internal medicine, ThioTEPA, Cancer, Induction chemotherapy, Surgery, Cyclophosphamide, Cisplatin

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2020: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W2763740706
doi	https://doi.org/10.1093/annonc/mdx365.077
ids.doi	https://doi.org/10.1093/annonc/mdx365.077
ids.mag	2763740706
ids.openalex	https://openalex.org/W2763740706
fwci	0.13361471
type	article
title	Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study
biblio.issue
biblio.volume	28
biblio.last_page	v104
biblio.first_page	v104
topics[0].id	https://openalex.org/T10123
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9919000267982483
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	DNA Repair Mechanisms
topics[1].id	https://openalex.org/T12829
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9829000234603882
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2740
topics[1].subfield.display_name	Pulmonary and Respiratory Medicine
topics[1].display_name	Advanced Breast Cancer Therapies
topics[2].id	https://openalex.org/T11914
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9822999835014343
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	PARP inhibition in cancer therapy
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9199960231781006
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2776694085
concepts[1].level	2
concepts[1].score	0.7758871912956238
concepts[1].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[1].display_name	Chemotherapy
concepts[2].id	https://openalex.org/C2781451048
concepts[2].level	4
concepts[2].score	0.6816740036010742
concepts[2].wikidata	https://www.wikidata.org/wiki/Q415588
concepts[2].display_name	Carboplatin
concepts[3].id	https://openalex.org/C530470458
concepts[3].level	3
concepts[3].score	0.679241418838501
concepts[3].wikidata	https://www.wikidata.org/wiki/Q128581
concepts[3].display_name	Breast cancer
concepts[4].id	https://openalex.org/C2775930923
concepts[4].level	4
concepts[4].score	0.6496769189834595
concepts[4].wikidata	https://www.wikidata.org/wiki/Q12859063
concepts[4].display_name	Metastatic breast cancer
concepts[5].id	https://openalex.org/C143998085
concepts[5].level	1
concepts[5].score	0.5992268323898315
concepts[5].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[5].display_name	Oncology
concepts[6].id	https://openalex.org/C126322002
concepts[6].level	1
concepts[6].score	0.581597626209259
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[6].display_name	Internal medicine
concepts[7].id	https://openalex.org/C2779968505
concepts[7].level	4
concepts[7].score	0.5765568614006042
concepts[7].wikidata	https://www.wikidata.org/wiki/Q416507
concepts[7].display_name	ThioTEPA
concepts[8].id	https://openalex.org/C121608353
concepts[8].level	2
concepts[8].score	0.538250207901001
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[8].display_name	Cancer
concepts[9].id	https://openalex.org/C2776611710
concepts[9].level	3
concepts[9].score	0.4799633026123047
concepts[9].wikidata	https://www.wikidata.org/wiki/Q16888295
concepts[9].display_name	Induction chemotherapy
concepts[10].id	https://openalex.org/C141071460
concepts[10].level	1
concepts[10].score	0.3649265170097351
concepts[10].wikidata	https://www.wikidata.org/wiki/Q40821
concepts[10].display_name	Surgery
concepts[11].id	https://openalex.org/C2776755627
concepts[11].level	3
concepts[11].score	0.22624629735946655
concepts[11].wikidata	https://www.wikidata.org/wiki/Q408524
concepts[11].display_name	Cyclophosphamide
concepts[12].id	https://openalex.org/C2778239845
concepts[12].level	3
concepts[12].score	0.1422765552997589
concepts[12].wikidata	https://www.wikidata.org/wiki/Q412415
concepts[12].display_name	Cisplatin
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9199960231781006
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/chemotherapy
keywords[1].score	0.7758871912956238
keywords[1].display_name	Chemotherapy
keywords[2].id	https://openalex.org/keywords/carboplatin
keywords[2].score	0.6816740036010742
keywords[2].display_name	Carboplatin
keywords[3].id	https://openalex.org/keywords/breast-cancer
keywords[3].score	0.679241418838501
keywords[3].display_name	Breast cancer
keywords[4].id	https://openalex.org/keywords/metastatic-breast-cancer
keywords[4].score	0.6496769189834595
keywords[4].display_name	Metastatic breast cancer
keywords[5].id	https://openalex.org/keywords/oncology
keywords[5].score	0.5992268323898315
keywords[5].display_name	Oncology
keywords[6].id	https://openalex.org/keywords/internal-medicine
keywords[6].score	0.581597626209259
keywords[6].display_name	Internal medicine
keywords[7].id	https://openalex.org/keywords/thiotepa
keywords[7].score	0.5765568614006042
keywords[7].display_name	ThioTEPA
keywords[8].id	https://openalex.org/keywords/cancer
keywords[8].score	0.538250207901001
keywords[8].display_name	Cancer
keywords[9].id	https://openalex.org/keywords/induction-chemotherapy
keywords[9].score	0.4799633026123047
keywords[9].display_name	Induction chemotherapy
keywords[10].id	https://openalex.org/keywords/surgery
keywords[10].score	0.3649265170097351
keywords[10].display_name	Surgery
keywords[11].id	https://openalex.org/keywords/cyclophosphamide
keywords[11].score	0.22624629735946655
keywords[11].display_name	Cyclophosphamide
keywords[12].id	https://openalex.org/keywords/cisplatin
keywords[12].score	0.1422765552997589
keywords[12].display_name	Cisplatin
language	en
locations[0].id	doi:10.1093/annonc/mdx365.077
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license	publisher-specific-oa
locations[0].pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/publisher-specific-oa
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1093/annonc/mdx365.077
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5017612284
authorships[0].author.orcid	https://orcid.org/0000-0001-6870-5785
authorships[0].author.display_name	Tessa G. Steenbruggen
authorships[0].countries	NL
authorships[0].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[0].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[0].institutions[0].id	https://openalex.org/I2898336195
authorships[0].institutions[0].ror	https://ror.org/03xqtf034
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I2898336195
authorships[0].institutions[0].country_code	NL
authorships[0].institutions[0].display_name	The Netherlands Cancer Institute
authorships[0].author_position	first
authorships[0].raw_author_name	T.G. Steenbruggen
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[1].author.id	https://openalex.org/A5005700434
authorships[1].author.orcid	https://orcid.org/0000-0002-3242-4989
authorships[1].author.display_name	Astrid N. Scholten
authorships[1].countries	NL
authorships[1].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[1].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[1].institutions[0].id	https://openalex.org/I2898336195
authorships[1].institutions[0].ror	https://ror.org/03xqtf034
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I2898336195
authorships[1].institutions[0].country_code	NL
authorships[1].institutions[0].display_name	The Netherlands Cancer Institute
authorships[1].author_position	middle
authorships[1].raw_author_name	A.N. Scholten
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[2].author.id	https://openalex.org/A5024765228
authorships[2].author.orcid
authorships[2].author.display_name	M-J.T. Vrancken-Peeters
authorships[2].countries	NL
authorships[2].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[2].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[2].institutions[0].id	https://openalex.org/I2898336195
authorships[2].institutions[0].ror	https://ror.org/03xqtf034
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I2898336195
authorships[2].institutions[0].country_code	NL
authorships[2].institutions[0].display_name	The Netherlands Cancer Institute
authorships[2].author_position	middle
authorships[2].raw_author_name	M-J.T. Vrancken-Peeters
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[3].author.id	https://openalex.org/A5111521133
authorships[3].author.orcid
authorships[3].author.display_name	Ingrid A.M. Mandjes
authorships[3].countries	NL
authorships[3].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[3].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[3].institutions[0].id	https://openalex.org/I2898336195
authorships[3].institutions[0].ror	https://ror.org/03xqtf034
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I2898336195
authorships[3].institutions[0].country_code	NL
authorships[3].institutions[0].display_name	The Netherlands Cancer Institute
authorships[3].author_position	middle
authorships[3].raw_author_name	I.A. Mandjes
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[4].author.id	https://openalex.org/A5109637141
authorships[4].author.orcid
authorships[4].author.display_name	M. Holtkamp
authorships[4].countries	NL
authorships[4].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[4].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[4].institutions[0].id	https://openalex.org/I2898336195
authorships[4].institutions[0].ror	https://ror.org/03xqtf034
authorships[4].institutions[0].type	healthcare
authorships[4].institutions[0].lineage	https://openalex.org/I2898336195
authorships[4].institutions[0].country_code	NL
authorships[4].institutions[0].display_name	The Netherlands Cancer Institute
authorships[4].author_position	middle
authorships[4].raw_author_name	M. Holtkamp
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[5].author.id	https://openalex.org/A5020517461
authorships[5].author.orcid	https://orcid.org/0000-0002-8940-2676
authorships[5].author.display_name	Jelle Wesseling
authorships[5].countries	NL
authorships[5].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[5].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[5].institutions[0].id	https://openalex.org/I2898336195
authorships[5].institutions[0].ror	https://ror.org/03xqtf034
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I2898336195
authorships[5].institutions[0].country_code	NL
authorships[5].institutions[0].display_name	The Netherlands Cancer Institute
authorships[5].author_position	middle
authorships[5].raw_author_name	J. Wesseling
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[6].author.id	https://openalex.org/A5107253101
authorships[6].author.orcid
authorships[6].author.display_name	SC Linn
authorships[6].countries	NL
authorships[6].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[6].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[6].institutions[0].id	https://openalex.org/I2898336195
authorships[6].institutions[0].ror	https://ror.org/03xqtf034
authorships[6].institutions[0].type	healthcare
authorships[6].institutions[0].lineage	https://openalex.org/I2898336195
authorships[6].institutions[0].country_code	NL
authorships[6].institutions[0].display_name	The Netherlands Cancer Institute
authorships[6].author_position	middle
authorships[6].raw_author_name	S.C. Linn
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[7].author.id	https://openalex.org/A5048535376
authorships[7].author.orcid	https://orcid.org/0000-0001-8088-9628
authorships[7].author.display_name	Gabe S. Sonke
authorships[7].countries	NL
authorships[7].affiliations[0].institution_ids	https://openalex.org/I2898336195
authorships[7].affiliations[0].raw_affiliation_string	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
authorships[7].institutions[0].id	https://openalex.org/I2898336195
authorships[7].institutions[0].ror	https://ror.org/03xqtf034
authorships[7].institutions[0].type	healthcare
authorships[7].institutions[0].lineage	https://openalex.org/I2898336195
authorships[7].institutions[0].country_code	NL
authorships[7].institutions[0].display_name	The Netherlands Cancer Institute
authorships[7].author_position	last
authorships[7].raw_author_name	G.S. Sonke
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10123
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9919000267982483
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	DNA Repair Mechanisms
related_works	https://openalex.org/W579378004, https://openalex.org/W4244617181, https://openalex.org/W2397146001, https://openalex.org/W4235863775, https://openalex.org/W2892057079, https://openalex.org/W193298332, https://openalex.org/W1994661110, https://openalex.org/W3088601335, https://openalex.org/W4388814761, https://openalex.org/W107259173
cited_by_count	1
counts_by_year[0].year	2020
counts_by_year[0].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1093/annonc/mdx365.077
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41454044
best_oa_location.source.issn	0923-7534, 1569-8041
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0923-7534
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license	publisher-specific-oa
best_oa_location.pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/publisher-specific-oa
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of Oncology
best_oa_location.landing_page_url	https://doi.org/10.1093/annonc/mdx365.077
primary_location.id	doi:10.1093/annonc/mdx365.077
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license	publisher-specific-oa
primary_location.pdf_url	https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx365.077/19938867/mdx365.077.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/publisher-specific-oa
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1093/annonc/mdx365.077
publication_date	2017-09-01
publication_year	2017
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year.max	94
cited_by_percentile_year.min	89
countries_distinct_count	1
institutions_distinct_count	8
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7599999904632568
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.49277585
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False